Muga R, Tor J, Sabria M, Melus R, Tudela P, Foz M; International Conference on AIDS.
Int Conf AIDS. 1992 Jul 19-24; 8: 177 (abstract no. PuC 8149).
Infectious Diseases Unit, Hospital Universitario Germans Trias i Pujol, Spain.
OBJECTIVE: To examine the epidemiologic association between HIV-1 infection and the duration of drug injection in heroin users. METHODS: Intravenous drug users (IVDUs) were recruited in a University Hospital attending drug abuse treatments, emergencies and medical or surgical complications in IVDUs from May 1984 to July 1990. Patients fulfilled a standardized questionnaire at the initial visit or admission: demographic (age, sex), socioeconomic (education, employment) and drug use practices (main drug, frequency, quantity and time elapsed from first injection). HIV-1 Ab was screened by EIA and confirmed by Western blot. RESULTS: Of 1.328 IVDUs tested, HIV-1 seroprevalence was 67.6%, the median age was 24.6 years and 77.5% were male. Evaluation of HIV-1 seroprevalence by duration of drug injection practices were obtained in 575 current active users; the median of drug injecting was 64.6 +/- 32 months: TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSION: A strong relationship between length of injection history and the likelihood of HIV infection is observed among IVDUs from Barcelona. The risk for infection might occur early during a drug injection career.
Publication Types:
Keywords:
- Crack Cocaine
- HIV Antibodies
- HIV Infections
- HIV Seroprevalence
- Heroin Dependence
- Humans
- Male
- Pharmaceutical Preparations
- Substance Abuse, Intravenous
Other ID:
UI: 102201547
From Meeting Abstracts